Read the article at Psychedelic Spotlight
Excerpt
The fact that executives often take psychedelics to “turn on, tune in, and drop out” is old news. Reports that the homes of Facebook, Apple, Google, and Twitter are swimming with Type-A professionals who are actively trying to expand their minds, boost creativity, and leapfrog competition by microdosing magic mushrooms and LSD were part of what ignited the microdosing trend in the first place.
According to a report by The Wall Street Journal, Tesla and Neuralink CEO Elon Musk takes ketamine while Google founder Sergey Brin prefers psilocybin mushrooms. …
